fda halts glp-1 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Federal judge upholds FDA's removal

Several health system initiatives are developing clinical pathways to integrate GMV models with prescribing obesity management medications [205]

The Precision Peptide Genetic Test ($99 add-on after your first month) identifies whether your genetic variants in GLP1R (rs6923761), GIPR (rs1800437), or MC4R (rs17782313) predict higher or lower sensitivity to GLP-1 effects, including gastrointestinal side effects

It is estimated that over four million Americans have Gastroparesis

Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans

Rare, More Serious Side Effects Anecdotal Side Effects There has also been plenty of media buzz about anecdotal side effects with names like Ozempic face and Ozempic butt. These cosmetic side effects arent unhealthy, and arent directly caused by GLP-1s

Higher doses often lead to more side effects, like headaches or grogginess, rather than better quality sleep